04:07 PM EDT, 03/15/2024 (MT Newswires) -- Andrew J Murphy, Executive Vice President, Research, on March 13, 2024, sold 5,783 shares in Regeneron Pharmaceuticals ( REGN ) for $5,531,290. Following the Form 4 filing with the SEC, Murphy has control over a total of 52,616 shares of the company, with 48,306 shares held directly and 4,310 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/872589/000196820224000086/xslF345X03/edgardoc.xml